These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24763031)

  • 1. [Preparation of tranexamic acid-loaded porous starch and evaluation of its hemostatic ability].
    Xi CY; Zhuang Y; Chen LF; Liu YQ; Wang SF; Wang DQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):503-8. PubMed ID: 24763031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Evaluation of Tranexamic Acid-Loaded Porous Starch as a Hemostatic Powder.
    Xi C; Zhu L; Zhuang Y; Wang S; Sun G; Liu Y; Wang D
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):279-286. PubMed ID: 28731369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study on hemostasis of a new chitosan hemostatic powder].
    Yin G; Hou C; Liu W; Han B; Wei C; Liu S; Guo X; Yu B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Nov; 23(11):1347-9. PubMed ID: 19968178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid-loaded catechol-modified hyaluronic acid/carboxymethyl chitosan double cross-linked porous gel micropowders for rapid hemostasis and wound healing.
    Tang C; Shi T; Xu G; Yin J; Yan S; Bao X
    Int J Biol Macromol; 2024 Aug; 275(Pt 1):133363. PubMed ID: 38914405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and the hemostatic property study of porous gelatin microspheres both in vitro and in vivo.
    Li L; Du Y; Yin Z; Li L; Peng H; Zheng H; Yang A; Li H; Lv G
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110641. PubMed ID: 31759778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid-loaded hemostatic nanoclay microsphere frameworks.
    Denry I; Nédélec JM; Holloway JA
    J Biomed Mater Res B Appl Biomater; 2022 Feb; 110(2):422-430. PubMed ID: 34288380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid-loaded starch hemostatic microspheres.
    Su H; Wei S; Chen F; Cui R; Liu C
    RSC Adv; 2019 Feb; 9(11):6245-6253. PubMed ID: 35517249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of tranexamic acid modified porous starch and its application as a hemostatic agent.
    Zhao X; Sun Y; Meng Z; Yang Z; Fan S; Ye T; Yang L; Li T; Gu R; Wu Z; Gan H; Dou G; Qi Y; Liu S
    Int J Biol Macromol; 2022 Mar; 200():273-284. PubMed ID: 35007632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized prospective analysis of alteration of hemostatic function in patients receiving tranexamic acid and hydroxyethyl starch (130/0.4) undergoing off pump coronary artery bypass surgery.
    Chakravarthy M; Muniraj G; Patil S; Suryaprakash S; Mitra S; Shivalingappa B
    Ann Card Anaesth; 2012; 15(2):105-10. PubMed ID: 22508200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iota-carrageenan/xyloglucan/serine powders loaded with tranexamic acid for simultaneously hemostatic, antibacterial, and antioxidant performance.
    de Moraes FM; Philippi JV; Belle F; da Silva FS; Morisso FDP; Volz DR; Ziulkoski AL; Bobinski F; Zepon ΚM
    Biomater Adv; 2022 Jun; 137():212805. PubMed ID: 35929232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of crosslinked porous starch hemostatic.
    Qian J; Chen Y; Yang H; Zhao C; Zhao X; Guo H
    Int J Biol Macromol; 2020 Oct; 160():429-436. PubMed ID: 32464204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the haemostatic efficiency of composite bio-particles].
    Li D; Gao H; Zang J; Diao J; Liu J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1141-4. PubMed ID: 22295702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of fast-swelling porous superabsorbent hydrogel based on starch as a hemostatic agent.
    Mirzakhanian Z; Faghihi K; Barati A; Momeni HR
    J Biomater Sci Polym Ed; 2015; 26(18):1439-51. PubMed ID: 26481485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-aggregating hydrogel particles for use as a hemostatic agent.
    Behrens AM; Sikorski MJ; Li T; Wu ZJ; Griffith BP; Kofinas P
    Acta Biomater; 2014 Feb; 10(2):701-8. PubMed ID: 24185001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quaternary Ammonium Groups Modified Starch Microspheres for Instant Hemorrhage Control.
    Chen F; Cao X; Yu J; Su H; Wei S; Hong H; Liu C
    Colloids Surf B Biointerfaces; 2017 Nov; 159():937-944. PubMed ID: 28922716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on hemostatic effect and mechanism of starch-based nano-microporous particles.
    Zheng C; Bai Q; Wu W; Han K; Zeng Q; Dong K; Zhang Y; Lu T
    Int J Biol Macromol; 2021 May; 179():507-518. PubMed ID: 33711370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic Efficacy and Biocompatibility Evaluation of a Novel Absorbable Porous Starch Hemostat.
    Zhu J; Wu Z; Sun W; Meng Z; Zhu X; Gan H; Gu R; Guo X; Dou G
    Surg Innov; 2022 Jun; 29(3):367-377. PubMed ID: 34551638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic enhancement of hemostatic performance of mesoporous silica by hydrocaffeic acid and chitosan.
    Chen J; Ai J; Chen S; Xu Z; Lin J; Liu H; Chen Q
    Int J Biol Macromol; 2019 Oct; 139():1203-1211. PubMed ID: 31415855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
    Ontachi Y; Asakura H; Takahashi Y; Hayashi T; Arahata M; Kadohira Y; Maekawa M; Omote M; Yoshida T; Yamazaki M; Morishita E; Miyamoto K; Nakao S
    Crit Care Med; 2006 Oct; 34(10):2646-50. PubMed ID: 16932226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid loaded in a physically crosslinked trilaminate dressing for local hemorrhage control: Preparation, characterization, and in-vivo assessment using two different animal models.
    El Halawany M; Khashaba M; AbouGhaly MHH; Latif R
    Int J Pharm; 2024 Jun; 659():124219. PubMed ID: 38734277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.